Security key
61225M102
Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE)
CUSIP: 61225M102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 84,039,109
- Total 13F shares
- 45,836,316
- Share change
- +5,937,410
- Total reported value
- $171,427,053
- Put/Call ratio
- 24%
- Price per share
- $3.74
- Number of holders
- 73
- Value change
- +$21,976,071
- Number of buys
- 44
- Number of sells
- 18
Report period
Q2 2024
Institutions
73
Top holders
10
GLUE full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Monte Rosa Therapeutics, Inc. SEC filings
Monte Rosa Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 61225M102
Recent filing periods:
Top shareholders of GLUE - Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
9.2%
|
7,692,298
|
$54,230,701 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
6.4%
|
5,340,802
|
$37,652,654 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.1%
|
5,096,787
|
$35,933,000 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.8%
|
4,916,095
|
$34,658,470 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
5.4%
|
4,535,000
|
$31,971,750 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.7%
|
2,307,009
|
$16,264,413 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
1,635,829
|
$11,532,595 | — | 31 Mar 2024 | |
| Aisling Capital Management LP |
13F
|
Company |
1.8%
|
1,472,331
|
$10,379,934 | — | 31 Mar 2024 | |
| Alphabet Inc. |
13F
|
Company |
1.7%
|
1,464,015
|
$10,321,305 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
980,239
|
$6,910,685 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
735,533
|
$5,186,095 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.73%
|
615,251
|
$4,337,520 | — | 31 Mar 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
0.61%
|
510,882
|
$3,601,718 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.35%
|
290,454
|
$2,047,701 | — | 31 Mar 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.32%
|
265,278
|
$1,870,000 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.3%
|
250,582
|
$1,766,603 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.23%
|
193,168
|
$1,361,834 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
150,025
|
$1,057,676 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.15%
|
122,100
|
$861,000 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.14%
|
120,647
|
$850,561 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.12%
|
103,087
|
$726,763 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
94,019
|
$662,834 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.11%
|
89,096
|
$628,127 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.09%
|
72,675
|
$512,359 | — | 31 Mar 2024 | |
| Sarasin & Partners LLP |
13F
|
Company |
0.08%
|
65,081
|
$458,821 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
62,109
|
$437,869 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
55,730
|
$392,896 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.07%
|
55,548
|
$390,000 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.06%
|
52,800
|
$372,240 | — | 31 Mar 2024 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.06%
|
46,787
|
$329,848 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
46,553
|
$328,189 | — | 31 Mar 2024 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.05%
|
42,393
|
$298,871 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
41,173
|
$290,269 | — | 31 Mar 2024 | |
| Long Corridor Asset Management Ltd |
13F
|
Company |
0.05%
|
40,000
|
$282,000 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.04%
|
33,848
|
$238,628 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
23,570
|
$166,169 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
22,163
|
$156,249 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
21,748
|
$153,324 | — | 31 Mar 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.02%
|
16,898
|
$119,131 | — | 31 Mar 2024 | |
| EntryPoint Capital, LLC |
13F
|
Company |
0.02%
|
15,893
|
$112,046 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.02%
|
15,803
|
$111,411 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
15,764
|
$111,136 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.02%
|
15,600
|
$109,980 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.02%
|
15,246
|
$107,484 | — | 31 Mar 2024 | |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
14,810
|
$115,370 | — | 31 Mar 2024 | |
| PDT Partners, LLC |
13F
|
Company |
0.02%
|
13,955
|
$98,383 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
13,388
|
$94,385 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
13,219
|
$93,194 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
12,821
|
$90,388 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
12,137
|
$85,566 | — | 31 Mar 2024 |
Institutional Holders of Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) as of Q2 2024
As of 30 Jun 2024,
Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,836,316 shares.
The largest 10 holders included
NEA Management Company, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., Aisling Capital Management LP, and Alphabet Inc..
This page lists
73
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
67
Q2 2024 holders
73
Holder diff
6
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.